Regeneron Pharmaceuticals, Inc. · NASDAQ:REGN
Fenimore Christopher R. exercised options for 6,283 Regeneron Pharmaceuticals, Inc. shares (Form 4)
Traded Aug 18, 2026 · Filed Aug 20, 2026
On Aug 18, 2026, Fenimore Christopher R. (EVP Finance CFO) exercised options for 6,283 Regeneron Pharmaceuticals, Inc. shares at US$381.92 for US$2.4M, leaving 19,984 shares. Filed Aug 20, 2026 (Form 4).
- Options exercised
- 6,283 shares
- Price
- US$381.92
- Value
- US$2.4M
- Holding after
- 19,984 shares
- Trading plan
- No
- Role
- EVP Finance CFO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 18, 2026 | Common Stock | Option exercise | 6,283 | US$381.92 | 24,583 | Direct |
| Aug 18, 2026 | Common Stock | Shares withheld for tax | 4,599 | US$813.47 | 19,984 | Direct |